Albany Molecular Research (AMRI) Tops Q1 EPS by 5c

Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $75.1 million versus the consensus estimate of $81.5 million.

For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery